Senior insider sale
VP of US Regulatory & FDA Rel. at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$625.0K
7.83K shares
What this filing means
PROVOST MIRIAM plans to sell 7.83K shares of TRANSMEDICS GROUP, INC. valued at approximately $625.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/13/2024ACC: 0001972362-24-000416
Officer· VP of US Regulatory & FDA Rel.
Since May 2019
7.83K
Shares to sell
$625.0K
Approx. market value
1.25K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RESTRICTED STOCK
COMPENSATION
2/20/2024
1.25KTotal acquired1.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2024 | RESTRICTED STOCK COMPENSATION | 1.25K | — |
| Total | 1.25K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.81K
Market value
$152.3K
3/12/2024
—Completed
Units to sell
647.00
Market value
$56.7K
3/8/2024
—Completed
Units to sell
4.12K
Market value
$309.5K
12/13/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.25K
Market value
$106.5K
3/13/2024
Total
Units
7.83K
Value
$625.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/12/2024 | 1.81K | $152.3K | — | Completed |
3/8/2024 | 647.00 | $56.7K | — | Completed |
12/13/2023 | 4.12K | $309.5K | — | Completed |
| Planned — Approximate Date | ||||
3/13/2024 | 1.25K | $106.5K | NASDAQ | Planned |
| Total | 7.83K | $625.0K | ||